- Following successful medical cannabis launch in Germany, Khiron 1/14, a high CBD flower is expected to be available in Q2/21 for UK patients
- Khiron plans to introduce additional cannabis-based medical products with its registered strains, recently exported from Colombia to Europe
- Supply chain improvements will increase availability of medical cannabis for patients in the United Kingdom
TORONTO, April 7, 2021 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX:…
